Market Signal Briefing

Scan QR code to install app

Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.

Tesla is planning to scale domestic solar production by sourcing nearly $2.9 billion worth of manufacturing equipment from Chinese suppliers, a Reuters report said on Friday.

The initiative aligns with Elon Musk’s broader goal of building large-scale solar capacity within the United States.

Internal hiring plans and public statements indicate Tesla is targeting 100 gigawatts of solar manufacturing output before the end of 2028.

Demand for clean energy is rising alongside the expansion of data centres and energy-intensive technologies.

The push also reflects growing pressure on US firms to secure reliable energy sources domestically.

China suppliers in focusSuzhou Maxwell Technologies has emerged as a key contender in Tesla’s procurement process.

The company is the world’s largest producer of screen-printing equipment used in solar cell production.

It is currently seeking export approval from China’s commerce ministry for the proposed deal, a step required for certain advanced manufacturing equipment shipments.

Other potential suppliers include Shenzhen S.C New Energy Technology and Laplace Renewable Energy Technology.

These companies are being considered to support Tesla’s planned buildout of solar manufacturing capacity.

The supplier mix highlights continued reliance on specialised Chinese equipment despite efforts to localise production.

Export approvals and timelinesThe equipment package, estimated at around 20 billion yuan, includes advanced screen-printing production lines used in solar cell manufacturing.

Some of this equipment will require export clearance from Chinese regulators, although it remains unclear how much of the total order falls under these restrictions.

There is also uncertainty around the approval timeline, which could influence delivery schedules. Suppliers have been instructed to complete shipments before autumn.

The equipment is expected to be transported to Texas, where Tesla is expanding its manufacturing footprint.

Any delays in approvals could affect installation timelines and production ramp-up schedules, potentially slowing initial output targets.

Scaling solar capacity in the USTesla’s procurement strategy reflects a broader push to localise solar manufacturing.

Job listings published by the company outline plans to establish a full supply chain on American soil, covering everything from raw materials to finished panels.

Elon Musk said in January that solar power could meet all electricity needs in the US, including rising demand from data centres.

The company’s internal targets suggest it is working towards deploying 100 gigawatts of solar manufacturing capacity annually, positioning solar as a key component of its long-term energy strategy.

This expansion also reflects wider industry shifts, where energy security and supply chain control are becoming central to manufacturing decisions, particularly in sectors linked to clean energy and artificial intelligence infrastructure.

Link to SpaceX and internal useThe planned solar capacity is expected to primarily support Tesla’s own operations. However, part of the output is also intended to power SpaceX satellites.

This integration points to a broader strategy where Tesla and SpaceX develop shared energy infrastructure.

Both companies are pursuing large-scale energy solutions, and the expansion of solar manufacturing could play a central role in supporting their future operations.

The approach suggests a move towards vertically integrated energy systems spanning production, storage, and consumption across multiple industries, linking energy generation directly with high-demand technology applications.

JD Wetherspoon PLC (LSE:JDW), the pub chain, has warned that full-year profits may come in slightly below market expectations as rising taxes, wages and energy costs weigh on the business.

Chairman Tim Martin said increases in national insurance and labour rates would add approximately £60 million to annual costs, with non-commodity energy costs adding a further £7 million and a new packaging levy costing £2.4 million in the current year.

The warning came alongside interim results showing a sharp fall in profitability despite healthy sales growth, with pre-tax profit dropping 31.9% to £22.4 million in the 26 weeks to 25 January 2026, against £32.9 million a year earlier.

Revenue rose 5.7% to £1.087 billion, with like-for-like sales up 4.8%.

Martin said the company had outperformed the wider hospitality sector for the 42nd consecutive month, with like-for-like sales up 3.2% in February against an industry average of -0.2%, according to the CGA RSM Hospitality Business Tracker, an industry benchmarking measure.

In the seven weeks to 15 March, like-for-like sales increased by 2.6%.

The group held its half-year dividend at 4p per share, unchanged from the prior year.

Martin pointed to "considerable pressure on consumer finances" alongside higher costs across the hospitality sector, though he said Wetherspoon would endeavour to keep price increases to a minimum.

The company said its forecast for year-end net debt remained unchanged.

Wetherspoon operates around 800 pubs across the UK and Ireland and has long positioned itself as a value-led operator, a strategy that has helped it outpace competitors during periods of consumer stress.

Alibaba has sharply reduced its workforce as it restructures its business and intensifies its focus on artificial intelligence.

The Chinese e-commerce and technology group ended December with 128,197 employees, down from 194,320 a year earlier, marking a decline of about 34% year over year.

The update came alongside its latest earnings report released Thursday, which showed a steep drop in profit and revenue that missed market expectations for the final quarter of last year.

Shares listed in Hong Kong fell 6% on Friday following the results, reflecting investor reaction to both the financial performance and the ongoing transition.

Retail exit drives cutsA large portion of the workforce reduction followed Alibaba’s exit from its offline retail businesses.

The company sold its stake in Sun Art Retail Group at the end of 2024 and also exited its investment in department store chain Intime around the same time.

These moves reduced the need for employees tied to physical retail operations.

Alibaba has historically operated a broad ecosystem that includes e-commerce platforms, logistics networks, and cloud services.

The recent changes show a shift away from labour-intensive segments and towards areas that require less physical infrastructure.

The scale of the cuts is significantly larger than previous adjustments.

In December 2024, Alibaba had already reduced its workforce by 11% compared with the prior year, indicating that the latest decline reflects a faster restructuring phase.

Earnings miss weighs on sharesThe workforce update came as part of Alibaba’s quarterly earnings disclosure.

The results showed profit plunging 67% for the period, while revenue came in below analyst expectations.

Investors responded quickly to the weaker performance, pushing the company’s Hong Kong-listed shares down by 6% on Friday.

The figures underline the pressure Alibaba faces as it reshapes its business while navigating slower growth in some of its traditional segments.

Alibaba remains China’s second-largest technology company by market capitalisation.

It is also part of a broader trend, with major technology firms globally reducing headcounts over the past year as they adjust to shifting economic conditions and evolving investment priorities.

AI strategy gains paceThe company is repositioning itself around artificial intelligence as a core growth driver.

Alibaba is working towards building a full-stack AI ecosystem that spans semiconductor development, computing infrastructure, and AI models.

As part of this strategy, the company launched an agentic AI service called Wukong for enterprise users this week.

It has also raised prices for its cloud and storage services by as much as 34%, citing strong demand and rising supply chain costs.

The focus on AI aligns with wider industry developments, as technology companies invest heavily in tools and infrastructure designed to support machine learning and automation.

Cloud ambitions shape future plansAlibaba’s leadership has outlined ambitious targets for its cloud and AI divisions.

During the earnings call on Thursday, CEO Eddie Wu said the company aims to grow its cloud and AI revenue to more than $100 billion annually within the next five years.

This goal highlights a long-term shift towards high-margin technology services and away from businesses linked to physical retail.

The transition requires continued investment and organisational changes as Alibaba adapts to a more technology-driven growth model.

CAB Payments Holdings PLC (LSE:CABP), the London-listed cross-border payments specialist, has unanimously rejected an unsolicited £241 million cash takeover bid from StoneX Group, the Nasdaq-listed financial services firm, saying the offer significantly undervalues the company.

StoneX proposed 95 pence per share, representing a 32% premium to CAB Payments' closing price of 72p before takeover interest in the company first emerged in January, and an 11% premium to a rival bid of 85p per share from the Helios Consortium, a private equity-led group.

The independent board said it had consulted with larger shareholders and, after evaluating the proposal alongside the company's improved financial and operational performance in its 2025 results, concluded it was not in shareholders' interests to engage.

The rejection leaves StoneX facing a deadline set by the Takeover Panel, the City regulator overseeing mergers and acquisitions, either to make a formal offer or walk away.

CAB Payments operates a regulated emerging markets payments network and positions itself as a relationship-led business serving banks, payment firms and multinational companies moving money across harder-to-reach currencies.

The company has been the subject of competing interest since the Helios Consortium announced a possible approach at the end of January, with StoneX entering as a rival suitor earlier this month arguing its payments operations were highly complementary to CAB Payments' business.

The Helios Consortium's own firm offer of 85p per share, announced on 2 March, had itself followed an earlier sweetened bid that was rejected by the board.

Shareholders have been advised to take no action while the process continues.

, /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nektar Therapeutics ("Nektar" or "the Company") (NASDAQ: NKTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 26, 2025 and December 15, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Nektar's enrollment of patients for the REZOLVE-AA trial of its product candidate, rezpegaldesleukin, failed to follow protocol standards. The company's enrollment problems were likely to have a negative impact on the trial's findings. The Company overstated the integrity of its REZOLVE-AA trial. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Nektar, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.             

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE The Schall Law Firm

, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nektar Therapeutics ("Nektar" or "the Company") (NASDAQ: NKTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of NKTR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 26, 2025 to December 15, 2025

DEADLINE: May 5, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Nektar failed to follow protocol standards in its REZOLVE-AA study of rezpegaldesleukin, which was likely to have a negative impact on the trial's results. Based on these facts, Nektar's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

 Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

SOURCE DJS Law Group LLP

Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-) breast cancer The lead asset, SNV4818, currently in a Phase 1/2 clinical study, is designed to selectively target PI3Kα mutations in breast cancer while sparing wild-type PI3Kα, thus reducing unwanted side effects and improving tolerabilityAddresses a well‑defined patient population with significant unmet need -- approximately 40% of HR+/HER2- breast cancer patients have PIK3CA mutations Basel, March 20, 2026 – Novartis today announced that it has entered into an agreement with Synnovation Therapeutics, LLC to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor, exploring a next-generation approach for the treatment of patients with HR+/HER2- breast cancer and potentially other solid tumor indications.

SNV4818 is an oral drug currently being evaluated in a Phase 1/2 study for breast cancer and other advanced solid tumors. The biology of mutated PI3Kα in HR+/HER2- breast cancer is well-understood, with approximately 40% of HR+/HER2- breast cancer patients potentially facing worse disease prognosis due to the presence of PIK3CA mutations in their tumors. The program is aligned with the Novartis commitment to developing treatments that improve the lives of patients with breast cancer. It fits naturally alongside CDK inhibitors as well as endocrine (hormonal) therapies as part of a potential combination regimen.

“While mutated PI3Kα is a well‑established driver in HR+/HER2‑ breast cancer, there remains a challenge in achieving effective pathway inhibition with a tolerable therapeutic profile,” said Shreeram Aradhye, M.D., President of Development at Novartis. “SNV4818 applies new mutant‑selective chemistry to more precisely target tumor biology while sparing normal cells. This approach has the potential to translate proven biology into improved tolerability and more durable benefit for patients through precision medicine.”

SNV4818 is designed to target the mutated PI3Kα enzyme found in cancer cells while sparing the wild-type (normal) PI3Kα in healthy cells. Available PI3Kα inhibitors block both mutant and wild-type PI3Kα, leading to tolerability challenges that make it difficult to keep patients on treatment. By focusing on the mutated form in tumors, SNV4818 aims to reduce unwanted side effects, support more consistent dosing, and make it easier to combine with hormonal therapy and other treatments earlier in care. Preclinical studies show strong activity against common PIK3CA mutations and clear selectivity over the normal enzyme, with clinical evaluation ongoing.

Transaction Details
Under the terms of the agreement, Novartis will pay USD 2 billion upfront and up to USD 1 billion in milestone payments to Synnovation Therapeutics, LLC to acquire Pikavation Therapeutics, Inc., a wholly- owned subsidiary of Synnovation that holds a portfolio of pan-mutant selective PI3Kα inhibitor programs, including SNV4818. The transaction is expected to close in H1 2026, subject to the satisfaction or waiver of customary closing conditions, including regulatory approvals. 

Novartis in oncology
The Novartis oncology strategy focuses on people living with cancer and those who care for them, from loved ones to clinical care teams, including their providers. For the past 30+ years, the aim has been to extend and improve lives by discovering differentiated, innovative and practice-changing medicines for patients.

As Novartis reimagines medicine, it collaborates with a wide range of patient advocacy groups and supports education, early cancer screening and diagnosis. With a broad research and development portfolio across solid tumors, hematology and radioligand therapy (RLT), Novartis is committed to using technology, leading science and patient-centered research to deliver pioneering cancer care for all those in need.

About Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.

Disclaimer

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “potential,” “can,” “will,” “plan,” “may,” “could,” “would,” “expect,” “anticipate,” “look forward,” or similar expressions, or by express or implied discussions regarding: potential new products or programs, including SNV4818; potential new indications for existing products; potential product launches or potential future revenues from any such products; results of ongoing clinical trials; or potential future, pending or announced transactions, including the acquisition of Pikavation Therapeutics, Inc.; or potential future sales or earnings. You should not place undue reliance on these statements. Such forward-looking statements are based on the current beliefs and expectations of management regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that SNV4818 will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Neither can there be any guarantee that the expected benefits or synergies from this transaction will be achieved in the expected timeframe, or at all, nor can there be any guarantee that SNV4818 will be commercially successful in the future. In particular, our expectations regarding SNV4818 or the transaction described in this press release could be affected by, among other things, the satisfaction of customary closing conditions including regulatory approvals, as well as uncertainties concerning: global healthcare cost containment, including ongoing government, payer and general public pricing and reimbursement pressures and requirements for increased pricing transparency; ; research and development of new products, including clinical trial results and additional analysis of existing clinical data; our ability to obtain or maintain proprietary intellectual property protection, including the ultimate extent of the impact on Novartis of the loss of patent protection and exclusivity on key products; our ability to realize the strategic benefits, operational efficiencies or opportunities expected from our external business opportunities; the development or adoption of new technologies, including artificial intelligence, and new business models; actual or potential legal proceedings, including regulatory actions or delays or government regulation related to the products and pipeline products described in this press release; safety, quality, data integrity, or manufacturing issues; major macroeconomic and geo- and socio-political developments, including the impact of any potential tariffs on our products or the impact of war in certain parts of the world; future demand for our products; and other risks and factors referred to in Novartis AG’s most recently filed Form 20-F and in subsequent reports filed with, or furnished to, the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.

# # #

6K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of TRIP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

WILMINGTON, Del.--(BUSINESS WIRE)--Synnovation Therapeutics, LLC (“Synnovation”), a clinical-stage biotechnology company with a diverse pipeline of novel small-molecule targeted therapies in oncology and immunology today announced a definitive agreement for Novartis to acquire Pikavation Therapeutics, Inc. (“Pikavation”) and its portfolio of PI3Kα inhibitor programs, including SNV4818. Pikavation is a wholly-owned subsidiary of Synnovation. SNV4818 is a potentially best-in-class pan-mutant sele.

, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Paysafe Limited ("Paysafe" or "the Company") (NYSE: PSFE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PSFE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: March 4, 2025 to November 12, 2025

DEADLINE: April 7, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Paysafe had significant exposure to a high credit risk client of its e-commerce business. The Company was likely to fall short of its previously issued financial guidance for fiscal year 2025. Based on these facts, Paysafe's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]

SOURCE DJS Law Group LLP

13.35K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Alibaba's workforce shrank by roughly 34% over the course of 2025, as the company offloaded some of its offline retail businesses while doubling down on artificial intelligence.

The Chinese e-commerce and technology giant ended December with 128,197 employees, down from 194,320 a year earlier.

The disclosure of its latest headcount came in an earnings report released Thursday that showed the firm's profit plunging 67% and its revenue missing expectations for the last three months of last year. 

The company's shares in Hong Kong were trading down 6% Friday. 

The bulk of Alibaba's workforce reduction was revealed in its March 2025 quarter following the sale of Sun Art retail group at the end of 2024. The tech giant also exited its stake in department store chain Intime around the same period.

China's second-largest tech company by market cap is amongst a raft of other major tech firms that have reduced headcounts in the past year from Silicon Valley to Hangzhou, China. 

Alibaba's staff has supported its sprawling network of business units spanning e-commerce, cloud, logistics, and other related services. 

However, Alibaba has been steadily reducing headcount in recent years, though the latest cuts were much larger than the 11% reduction in December 2024 from the prior year.

This comes as Alibaba has sought to offload labor-intensive holdings and restructure its core businesses, with a major focus on artificial intelligence.

The tech giant aims to become a full-stack AI company spanning semiconductor manufacturing to computing and AI models. 

The company this week launched an agentic AI service known as Wukong for businesses, and hiked prices for its cloud and storage services by as much as 34% due to rising demand and supply chain costs.

Alibaba CEO Eddie Wu said during an earnings call Thursday that the company aimed to grow its cloud and AI revenue to over $100 billion annually over the next five years.

HAMILTON, Bermuda, March 20, 2026 /PRNewswire/ -- FLEX LNG Ltd. (NYSE: FLNG) ("FLNG" or the "Company") advises that the 2026 Annual General Meeting of the Company will be held on 5 May 2026. The record date for voting at the Annual General Meeting is set to 24 March 2026. A copy of the Notice of Annual General Meeting and associated information, including the Company's Annual Report on Form 20-F, will be distributed and made available on the Company's website at www.flexlng.com prior to the meeting.

The Board of Directors
FLEX LNG Ltd.
Hamilton, Bermuda

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/flex-lng/r/flex-lng---notice-of-annual-general-meeting-2026,c4324143

SOURCE Flex LNG

By Reuters

March 20, 20266:25 AM UTCUpdated 13 mins ago

The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann Purchase Licensing Rights, opens new tab

FRANKFURT, March 20 (Reuters) - Novartis (NOVN.S), opens new tab said on ​Friday it agreed ‌to acquire breast cancer drug ​candidate SNV4818 ​from Synnovation Therapeutics for $2 ⁠billion upfront ​and up to $1 ​billion contingent on further development achievements.

The experimental ​drug belongs ​to the class of ‌selective ⁠PI3Kα inhibitors, a new approach for the ​treatment ​of ⁠a type of breast ​cancer known ​as ⁠HR positive/HER2 negative and potentially ⁠other ​solid tumours.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Reporting ​by Ludwig Burger; Editing ​by Himani Sarkar

Our Standards: The Thomson Reuters Trust Principles., opens new tab

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES

London, 20 March 2026 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited.

Aggregated information

Dates of purchase:19 March 2026Aggregate number of ordinary shares of USD 0.01 each purchased:60,000Lowest price paid per share (GBp):                3,964.00Highest price paid per share (GBp):        4,384.08Volume weighted average price paid per share (GBp):        4,223.07 Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 242,512,242 ordinary shares in issue. Therefore the total voting rights in the Company will be 242,512,242. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

These share purchases form part of the Company’s buy-back programme announced on 20 March 2025.

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Stifel Nicolaus Europe Limited as part of the buyback programme.

Schedule of purchases

Shares purchased: Endeavour Mining plc (ISIN: GB00BL6K5J42)

Dates of purchases: 19 March 2026

Investment firm: Stifel Nicolaus Europe Limited

Individual transactions

Transaction date and timeVolumePrice (GBp)Trading Venue19 Mar 2026, 06:29 AM30,0004,384.08TSX*19 Mar 2026, 08:08 AM2514,158.00LSE19 Mar 2026, 08:08 AM134,158.00LSE19 Mar 2026, 08:08 AM834,158.00LSE19 Mar 2026, 08:09 AM1144,158.00LSE19 Mar 2026, 08:09 AM414,158.00LSE19 Mar 2026, 08:09 AM1144,158.00LSE19 Mar 2026, 08:09 AM94,158.00LSE19 Mar 2026, 08:09 AM94,158.00LSE19 Mar 2026, 08:09 AM1084,158.00LSE19 Mar 2026, 08:09 AM1254,158.00LSE19 Mar 2026, 08:09 AM1254,158.00LSE19 Mar 2026, 08:09 AM1264,158.00LSE19 Mar 2026, 08:09 AM2514,158.00LSE19 Mar 2026, 08:09 AM2514,158.00LSE19 Mar 2026, 08:09 AM2514,158.00LSE19 Mar 2026, 08:09 AM984,158.00LSE19 Mar 2026, 08:09 AM314,158.00LSE19 Mar 2026, 08:28 AM2504,136.00LSE19 Mar 2026, 08:28 AM694,136.00LSE19 Mar 2026, 08:28 AM484,136.00LSE19 Mar 2026, 08:28 AM1334,136.00LSE19 Mar 2026, 08:28 AM1174,136.00LSE19 Mar 2026, 08:28 AM2504,136.00LSE19 Mar 2026, 08:28 AM1334,136.00LSE19 Mar 2026, 09:51 AM464,134.00LSE19 Mar 2026, 09:51 AM764,134.00LSE19 Mar 2026, 09:51 AM1284,134.00LSE19 Mar 2026, 09:51 AM2504,134.00LSE19 Mar 2026, 09:51 AM2504,134.00LSE19 Mar 2026, 10:17 AM2504,134.00LSE19 Mar 2026, 10:17 AM2504,134.00LSE19 Mar 2026, 10:17 AM2504,134.00LSE19 Mar 2026, 10:17 AM2504,134.00LSE19 Mar 2026, 10:17 AM2504,134.00LSE19 Mar 2026, 10:22 AM134,118.00LSE19 Mar 2026, 10:41 AM2384,118.00LSE19 Mar 2026, 10:41 AM414,118.00LSE19 Mar 2026, 10:41 AM2104,118.00LSE19 Mar 2026, 10:41 AM414,118.00LSE19 Mar 2026, 10:41 AM2514,118.00LSE19 Mar 2026, 10:41 AM524,118.00LSE19 Mar 2026, 10:41 AM354,118.00LSE19 Mar 2026, 10:41 AM174,118.00LSE19 Mar 2026, 10:41 AM1024,118.00LSE19 Mar 2026, 11:05 AM74,098.00LSE19 Mar 2026, 11:05 AM2084,098.00LSE19 Mar 2026, 11:05 AM74,098.00LSE19 Mar 2026, 11:05 AM1964,098.00LSE19 Mar 2026, 11:05 AM194,098.00LSE19 Mar 2026, 11:05 AM1894,098.00LSE19 Mar 2026, 11:05 AM864,098.00LSE19 Mar 2026, 11:08 AM1294,098.00LSE19 Mar 2026, 11:08 AM1384,098.00LSE19 Mar 2026, 11:08 AM214,098.00LSE19 Mar 2026, 11:26 AM2154,090.00LSE19 Mar 2026, 11:26 AM2154,090.00LSE19 Mar 2026, 11:26 AM1384,090.00LSE19 Mar 2026, 11:26 AM84,090.00LSE19 Mar 2026, 11:26 AM474,090.00LSE19 Mar 2026, 11:26 AM64,090.00LSE19 Mar 2026, 11:26 AM324,090.00LSE19 Mar 2026, 11:26 AM1224,090.00LSE19 Mar 2026, 11:26 AM384,090.00LSE19 Mar 2026, 11:26 AM864,090.00LSE19 Mar 2026, 11:26 AM934,090.00LSE19 Mar 2026, 11:46 AM2514,080.00LSE19 Mar 2026, 11:46 AM544,080.00LSE19 Mar 2026, 11:46 AM2514,080.00LSE19 Mar 2026, 11:46 AM1584,080.00LSE19 Mar 2026, 11:46 AM164,080.00LSE19 Mar 2026, 11:46 AM2354,080.00LSE19 Mar 2026, 11:46 AM354,080.00LSE19 Mar 2026, 12:00 PM2504,074.00LSE19 Mar 2026, 12:00 PM2504,074.00LSE19 Mar 2026, 12:00 PM2504,074.00LSE19 Mar 2026, 12:00 PM2504,074.00LSE19 Mar 2026, 12:10 PM694,054.00LSE19 Mar 2026, 12:11 PM1464,054.00LSE19 Mar 2026, 12:11 PM244,054.00LSE19 Mar 2026, 12:11 PM1384,054.00LSE19 Mar 2026, 12:11 PM534,054.00LSE19 Mar 2026, 12:11 PM2154,054.00LSE19 Mar 2026, 12:11 PM614,054.00LSE19 Mar 2026, 12:11 PM2154,054.00LSE19 Mar 2026, 12:11 PM534,054.00LSE19 Mar 2026, 12:11 PM2154,054.00LSE19 Mar 2026, 12:11 PM434,054.00LSE19 Mar 2026, 12:11 PM1874,054.00LSE19 Mar 2026, 12:11 PM284,054.00LSE19 Mar 2026, 12:11 PM344,054.00LSE19 Mar 2026, 12:11 PM2154,054.00LSE19 Mar 2026, 12:11 PM994,054.00LSE19 Mar 2026, 12:11 PM2054,054.00LSE19 Mar 2026, 12:44 PM1124,020.00LSE19 Mar 2026, 12:44 PM124,020.00LSE19 Mar 2026, 12:44 PM914,020.00LSE19 Mar 2026, 12:44 PM14,020.00LSE19 Mar 2026, 12:44 PM2154,020.00LSE19 Mar 2026, 12:44 PM2154,020.00LSE19 Mar 2026, 12:44 PM2154,020.00LSE19 Mar 2026, 12:44 PM1394,020.00LSE19 Mar 2026, 12:47 PM2504,004.00LSE19 Mar 2026, 12:47 PM144,004.00LSE19 Mar 2026, 12:47 PM524,004.00LSE19 Mar 2026, 12:47 PM1844,004.00LSE19 Mar 2026, 12:47 PM664,004.00LSE19 Mar 2026, 12:47 PM1904,004.00LSE19 Mar 2026, 12:47 PM604,004.00LSE19 Mar 2026, 12:47 PM124,004.00LSE19 Mar 2026, 12:47 PM1784,004.00LSE19 Mar 2026, 12:47 PM724,004.00LSE19 Mar 2026, 12:47 PM1764,004.00LSE19 Mar 2026, 12:47 PM664,004.00LSE19 Mar 2026, 12:47 PM84,004.00LSE19 Mar 2026, 12:47 PM2794,004.00LSE19 Mar 2026, 12:47 PM674,004.00LSE19 Mar 2026, 12:47 PM1834,004.00LSE19 Mar 2026, 12:47 PM584,004.00LSE19 Mar 2026, 12:47 PM854,004.00LSE19 Mar 2026, 01:02 PM1623,994.00LSE19 Mar 2026, 01:06 PM2504,002.00LSE19 Mar 2026, 01:06 PM724,002.00LSE19 Mar 2026, 01:06 PM114,002.00LSE19 Mar 2026, 01:06 PM1674,002.00LSE19 Mar 2026, 01:06 PM2664,002.00LSE19 Mar 2026, 01:06 PM2504,002.00LSE19 Mar 2026, 01:06 PM4334,002.00LSE19 Mar 2026, 01:06 PM164,002.00LSE19 Mar 2026, 01:06 PM334,002.00LSE19 Mar 2026, 01:06 PM2014,002.00LSE19 Mar 2026, 01:06 PM494,002.00LSE19 Mar 2026, 01:06 PM124,002.00LSE19 Mar 2026, 01:06 PM784,002.00LSE19 Mar 2026, 01:30 PM2503,996.00LSE19 Mar 2026, 01:30 PM303,996.00LSE19 Mar 2026, 01:30 PM2203,996.00LSE19 Mar 2026, 01:30 PM213,996.00LSE19 Mar 2026, 01:30 PM2413,996.00LSE19 Mar 2026, 01:36 PM93,996.00LSE19 Mar 2026, 01:36 PM2293,996.00LSE19 Mar 2026, 01:47 PM2503,964.00LSE19 Mar 2026, 01:47 PM2503,964.00LSE19 Mar 2026, 01:47 PM843,964.00LSE19 Mar 2026, 01:47 PM353,964.00LSE19 Mar 2026, 01:47 PM2153,964.00LSE19 Mar 2026, 01:47 PM1193,964.00LSE19 Mar 2026, 01:47 PM473,964.00LSE19 Mar 2026, 02:10 PM2504,028.00LSE19 Mar 2026, 02:10 PM2504,028.00LSE19 Mar 2026, 02:10 PM1104,028.00LSE19 Mar 2026, 02:10 PM394,028.00LSE19 Mar 2026, 02:10 PM504,028.00LSE19 Mar 2026, 02:10 PM1194,028.00LSE19 Mar 2026, 02:10 PM424,028.00LSE19 Mar 2026, 02:10 PM1194,028.00LSE19 Mar 2026, 02:10 PM214,028.00LSE19 Mar 2026, 02:18 PM1234,002.00LSE19 Mar 2026, 02:19 PM114,002.00LSE19 Mar 2026, 02:19 PM744,002.00LSE19 Mar 2026, 02:19 PM424,002.00LSE19 Mar 2026, 02:19 PM324,002.00LSE19 Mar 2026, 02:19 PM2504,002.00LSE19 Mar 2026, 02:19 PM2504,002.00LSE19 Mar 2026, 02:19 PM674,002.00LSE19 Mar 2026, 02:19 PM1514,002.00LSE19 Mar 2026, 02:43 PM244,064.00LSE19 Mar 2026, 02:43 PM124,064.00LSE19 Mar 2026, 02:45 PM1564,064.00LSE19 Mar 2026, 02:45 PM224,064.00LSE19 Mar 2026, 02:45 PM364,064.00LSE19 Mar 2026, 02:45 PM1824,064.00LSE19 Mar 2026, 02:45 PM74,064.00LSE19 Mar 2026, 02:45 PM574,064.00LSE19 Mar 2026, 02:45 PM64,064.00LSE19 Mar 2026, 02:45 PM1804,064.00LSE19 Mar 2026, 02:45 PM2504,064.00LSE19 Mar 2026, 02:45 PM264,064.00LSE19 Mar 2026, 02:45 PM154,064.00LSE19 Mar 2026, 02:45 PM24,064.00LSE19 Mar 2026, 02:45 PM254,064.00LSE19 Mar 2026, 02:59 PM214,058.00LSE19 Mar 2026, 02:59 PM1004,058.00LSE19 Mar 2026, 02:59 PM1104,058.00LSE19 Mar 2026, 02:59 PM194,058.00LSE19 Mar 2026, 02:59 PM364,058.00LSE19 Mar 2026, 02:59 PM254,058.00LSE19 Mar 2026, 02:59 PM104,058.00LSE19 Mar 2026, 02:59 PM854,058.00LSE19 Mar 2026, 02:59 PM524,058.00LSE19 Mar 2026, 02:59 PM104,058.00LSE19 Mar 2026, 02:59 PM324,058.00LSE19 Mar 2026, 02:59 PM2134,058.00LSE19 Mar 2026, 02:59 PM374,058.00LSE19 Mar 2026, 02:59 PM2054,058.00LSE19 Mar 2026, 02:59 PM454,058.00LSE19 Mar 2026, 03:08 PM2504,072.00LSE19 Mar 2026, 03:08 PM2504,072.00LSE19 Mar 2026, 03:08 PM1184,072.00LSE19 Mar 2026, 03:08 PM634,072.00LSE19 Mar 2026, 03:08 PM1874,072.00LSE19 Mar 2026, 03:08 PM1324,072.00LSE19 Mar 2026, 03:51 PM2524,058.00LSE19 Mar 2026, 03:51 PM2334,058.00LSE19 Mar 2026, 03:51 PM194,058.00LSE19 Mar 2026, 03:51 PM1814,058.00LSE19 Mar 2026, 03:51 PM1114,058.00LSE19 Mar 2026, 03:51 PM1004,058.00LSE19 Mar 2026, 03:51 PM414,058.00LSE19 Mar 2026, 03:51 PM1034,058.00LSE19 Mar 2026, 03:51 PM14,058.00LSE19 Mar 2026, 03:51 PM2514,058.00LSE19 Mar 2026, 03:51 PM2524,058.00LSE19 Mar 2026, 03:51 PM364,058.00LSE19 Mar 2026, 03:51 PM2374,058.00LSE19 Mar 2026, 03:51 PM154,058.00LSE19 Mar 2026, 03:51 PM1684,058.00LSE19 Mar 2026, 04:10 PM2504,056.00LSE19 Mar 2026, 04:10 PM1554,056.00LSE19 Mar 2026, 04:10 PM954,056.00LSE19 Mar 2026, 04:10 PM1634,056.00LSE19 Mar 2026, 04:10 PM524,056.00LSE19 Mar 2026, 04:10 PM354,056.00LSE19 Mar 2026, 04:10 PM224,056.00LSE19 Mar 2026, 04:10 PM1114,056.00LSE19 Mar 2026, 04:10 PM84,056.00LSE19 Mar 2026, 04:10 PM1094,056.00LSE19 Mar 2026, 04:10 PM2504,056.00LSE19 Mar 2026, 04:10 PM2984,056.00LSE19 Mar 2026, 04:10 PM694,056.00LSE19 Mar 2026, 04:10 PM1814,056.00LSE19 Mar 2026, 04:10 PM2024,056.00LSE19 Mar 2026, 04:22 PM164,062.00LSE19 Mar 2026, 04:22 PM104,062.00LSE19 Mar 2026, 04:22 PM94,062.00LSE19 Mar 2026, 04:22 PM414,062.00LSE19 Mar 2026, 04:22 PM1554,062.00LSE19 Mar 2026, 04:22 PM14,062.00LSE19 Mar 2026, 04:22 PM194,062.00LSE19 Mar 2026, 04:23 PM424,062.00LSE19 Mar 2026, 04:25 PM654,066.00LSE19 Mar 2026, 04:25 PM234,066.00LSE19 Mar 2026, 04:25 PM224,066.00LSE19 Mar 2026, 04:25 PM204,066.00LSE19 Mar 2026, 04:25 PM154,066.00LSE19 Mar 2026, 04:25 PM124,066.00LSE19 Mar 2026, 04:25 PM304,066.00LSE19 Mar 2026, 04:25 PM644,066.00LSE19 Mar 2026, 04:25 PM2024,066.00LSE19 Mar 2026, 04:25 PM494,066.00LSE19 Mar 2026, 04:25 PM1864,066.00LSE19 Mar 2026, 04:25 PM254,066.00LSE19 Mar 2026, 04:25 PM404,066.00LSE19 Mar 2026, 04:25 PM254,066.00LSE19 Mar 2026, 04:25 PM1564,066.00LSE19 Mar 2026, 04:25 PM954,066.00LSE19 Mar 2026, 04:25 PM324,066.00LSE19 Mar 2026, 04:25 PM2514,066.00LSE19 Mar 2026, 04:25 PM1144,066.00LSE19 Mar 2026, 04:25 PM1004,066.00LSE19 Mar 2026, 04:25 PM374,066.00LSE19 Mar 2026, 04:25 PM634,066.00LSE19 Mar 2026, 04:25 PM344,066.00LSE19 Mar 2026, 04:25 PM124,066.00LSE19 Mar 2026, 04:25 PM84,066.00LSE19 Mar 2026, 04:25 PM154,066.00LSE19 Mar 2026, 04:25 PM124,066.00LSE *79.8736 CAD/share at 1.8219 CAD/GBP

CONTACT INFORMATION

For Investor Relations Enquiries:For Media Enquiries:Jack GarmanBrunswick Group LLP in LondonVice President of Investor RelationsCarole Cable, Partner+44 203 011 2723+ 44 207 404 [email protected]@brunswickgroup.com ABOUT ENDEAVOUR MINING PLC

Endeavour Mining is one of the world’s senior gold producers and the largest in West Africa, with operating assets across Senegal, Cote d’Ivoire and Burkina Faso and a strong portfolio of advanced development projects and exploration assets in the highly prospective Birimian Greenstone Belt across West Africa.

A member of the World Gold Council, Endeavour is committed to the principles of responsible mining and delivering sustainable value to its employees, stakeholders and the communities where it operates. Endeavour is admitted to listing and to trading on the London Stock Exchange and the Toronto Stock Exchange, under the symbol EDV.

For more information, please visit www.endeavourmining.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking statements" within the meaning of applicable securities laws.  All statements, other than statements of historical fact, are "forward-looking statements". Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects", "expected", "budgeted", "forecasts", and "anticipates".

Forward-looking statements, while based on management's best estimates and assumptions, are subject to risks and uncertainties that may cause actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the successful integration of acquisitions; risks related to international operations; risks related to general economic conditions and credit availability, actual results of current exploration activities, unanticipated reclamation expenses; changes in project parameters as plans continue to be refined; fluctuations in prices of metals including gold; fluctuations in foreign currency exchange rates, increases in market prices of mining consumables, possible variations in ore reserves, grade or recovery rates; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes, title disputes, claims and limitations on insurance coverage and other risks of the mining industry; delays in the completion of development or construction activities, changes in national and local government regulation of mining operations, tax rules and regulations, and political and economic developments in countries in which Endeavour operates. Although Endeavour has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Please refer to Endeavour's most recent Annual Information Form filed under its profile at www.sedarplus.ca for further information respecting the risks affecting Endeavour and its business.

Transaction in own shares

SNV4818 is being evaluated in an early and mid-stage study for breast cancer and other advanced solid tumors, Novartis said.

, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Apollo Global Management, Inc. ("Apollo" or "the Company") (NYSE: APO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of APO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: May 10, 2021 to February 21, 2026

DEADLINE: May 1, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Top Apollo executives maintained contact and business ties with Jeffrey Epstein during the 2010's, despite the Company's claims of having no relationship with Epstein. When the extent of the relationship was revealed, the Company was at risk of reputational harm. Based on these facts, Apollo's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

 Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

SOURCE DJS Law Group LLP

A drone view shows Serbia's majority Russian-owned NIS oil refinery in Pancevo, Serbia, November 27, 2025. REUTERS/Marko Djurica Purchase Licensing Rights, opens new tab

CompaniesBELGRADE, March 20 (Reuters) - The U.S. Treasury Department has extended a sanctions waiver for Serbia's Russian-owned NIS (NIIS.BEL), opens new tab until April 17, ​giving the Balkan country more time to import crude oil ‌amid the U.S.-Israeli war on Iran, Serbia's energy minister said on Friday.

"The extension of the licence for almost a month is particularly important now when oil prices are jumping ... ​daily," Energy Minister Dubravka Djedovic Handanovic said in a statement.

The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.

NIS operates ​Serbia's only oil refinery in the town of Pancevo, just ⁠outside Belgrade and is the biggest supplier and fuel retailer in ​the Balkan country.

Serbia on Thursday extended a ban on crude oil and fuel ​product exports until April 2 to safeguard its market from shortages and price spikes stemming from the war on Iran.

The suspension applies to the export of diesel, gasoline and ​crude oil by all modes of transport.

Kazakhstan was Serbia's largest crude ​supplier last year, accounting for nearly 60% of imports, followed by Nigeria and Guyana.

All imported ‌crude ⁠arrives via tankers to the Croatian island of Krk and is then transported through the JANAF (JANF.ZA), opens new tab pipeline.

Serbia's populist President Aleksandar Vucic said he would announce more fuel and energy savings measures after he meets the country's National ​Security Council later ​on Friday.

In December, ⁠the U.S. Treasury's Office of Foreign Assets Control (OFAC) gave NIS until March 24 to negotiate the divestment of ​the stakes held by Russian firms Gazprom (GAZP.MM), opens new tab and Gazprom Neft (SIBN.MM), opens new tab, ​at ⁠44.9% and 11.3% respectively.

On January 19, Hungary's MOL (MOLB.BU), opens new tab said it had signed a binding agreement with the Russian companies to buy their stakes in NIS and ⁠the ​United Arab Emirates' ADNOC would be a minority ​stakeholder.

The Serbian government has a 29.9% stake in NIS, while the remainder belongs to small ​shareholders and employees.

Reporting by Aleksandar Vasovic; Editing by Muralikumar Anantharaman and Jamie Freed

Our Standards: The Thomson Reuters Trust Principles., opens new tab

XRP price extended losses and traded below $1.50. The price is now consolidating losses but faces hurdles near $1.4650 and $1.50.

XRP price started another decline and traded below the $1.50 zone. The price is now trading below $1.480 and the 100-hourly Simple Moving Average. There was a break above a key bearish trend line with resistance at $1.4450 on the hourly chart of the XRP/USD pair (data source from Kraken). The pair could continue to move down if it stays below $1.50. XRP Price Extends Losses XRP price failed to stay above $1.5350 and extended its decline, like Bitcoin and Ethereum. The price declined below $1.520 and $1.50 to enter a short-term bearish zone.

The price even extended losses below $1.450. A low was formed at $1.4228, and the price is now consolidating losses below the 23.6% Fib retracement level of the downward move from the $1.6068 swing high to the $1.4228 low.

Recently, there was a break above a key bearish trend line with resistance at $1.4450 on the hourly chart of the XRP/USD pair. The pair is now trading below $1.50 and the 100-hourly Simple Moving Average. If there is a fresh recovery move, the price might face resistance near the $1.4650 level.

The first major resistance is near the $1.4920 level. The main resistance could be $1.50. A close above $1.50 could send the price to $1.520. The next hurdle sits at $1.5360 or the 61.8% Fib retracement level of the downward move from the $1.6068 swing high to the $1.4228 low.

Source: XRPUSD on TradingView.com A clear move above the $1.5360 resistance might send the price toward the $1.5620 resistance. Any more gains might send the price toward the $1.5750 resistance. The next major hurdle for the bulls might be near $1.60.

Another Decline? If XRP fails to clear the $1.50 resistance zone, it could start a fresh decline. Initial support on the downside is near the $1.440 level. The next major support is near the $1.4220 level.

If there is a downside break and a close below the $1.4220 level, the price might continue to decline toward $1.4050. The next major support sits near the $1.3880 zone, below which the price could continue lower toward $1.3650.

Technical Indicators

Hourly MACD – The MACD for XRP/USD is now losing pace in the bearish zone.

Hourly RSI (Relative Strength Index) – The RSI for XRP/USD is now above the 50 level.

Major Support Levels – $1.4400 and $1.4220.

Major Resistance Levels – $1.4650 and $1.5000.

Bitcoin (BTC) hovered around the closely watched $70,000 level on Friday, as thinning volume signaled a shift toward a more cautious, wait-and-see market after a brief rebound attempt.As of 14:55 UTC on March 20, BTC was trading near $70,489, down 0.94% on the day. The pullback kept price action pinned to the low-$70,000s, with traders largely focused on defending the round-number threshold rather than pushing a directional breakout.Spot and derivatives activity also cooled. Reported 24-hour trading volume fell 2.37% to about $44.96 billion, a combination that typically points to reduced short-term conviction—less aggressive buying into dips and less urgency to sell rallies—while near-term volatility compresses.Recent daily moves underscore the choppy tone. Over the last five sessions, Bitcoin’s daily change has swung between sharp losses and modest recoveries: +2.81% (March 16), -1.28% (March 17), -3.58% (March 18), -1.82% (March 19), and +0.83% (March 20). The pattern suggests that the post-drop rebound has partially stabilized prices, but momentum remains fragile.Traditional markets offered a defensive backdrop. The S&P 500 slipped 0.27% to 6,606.49, while gold climbed 1.97% to $4,697, a divergence that reflects a broader tilt away from risk assets and toward perceived safe havens—conditions that often cap upside follow-through in crypto.Momentum indicators painted a mixed picture. The daily MACD remained positive at 412.25, but the rate of improvement eased, implying that bullish impulse is fading. On a weekly basis, MACD stayed deeply negative at -9,241.54, reinforcing the idea that medium-term pressure is still tilted to the downside despite short-term stabilization.Investor positioning also leaned defensive. Bitcoin dominance rose to 58.30% (+0.35%), typically read as capital concentrating in BTC relative to altcoins during periods of uncertainty. Meanwhile, the Crypto Fear & Greed Index held at 31 in the 'fear' zone, indicating that risk appetite remains subdued across the market.Public attention failed to reaccelerate alongside price. Google Trends interest slipped to 54 from 57, suggesting the bounce has not yet translated into broader participation—often a sign that rallies are being driven by existing traders rather than new inflows.Stablecoin buying power looked steady but not emphatic. The SSR (Stablecoin Supply Ratio) eased to 10.13 from 10.31, hinting at slightly improved sidelined 'liquidity' relative to Bitcoin’s market cap, though the shift was small enough to be considered neutral rather than decisively supportive.On-chain profitability cooled as well. NUPL (Net Unrealized Profit/Loss) declined to 0.2226 from 0.2367, implying fewer unrealized gains across the market and a narrower profit cushion—conditions that can reduce speculative risk-taking while keeping intermittent profit-taking in play.Exchange data suggested limited immediate sell pressure but also limited upside fuel. Exchange-held BTC slipped 0.05% to roughly 2.7246 million coins, while net flows remained negative at -1,523 BTC, reflecting continued net withdrawals. That pattern is generally consistent with longer-term holding behavior, though the magnitude was not large enough to dictate near-term direction on its own.Network activity inched higher, with active wallets rising to about 623,571 from 622,460 the prior day. The increase was modest, indicating incremental engagement rather than a decisive surge that would typically accompany a strong trend reversal.For now, Bitcoin’s battle around $70,000 looks less like a launchpad and more like a consolidation zone, with declining volume, lingering 'fear' sentiment, and risk-off cues from broader markets shaping a cautious tone. The next meaningful move is likely to depend on whether fresh liquidity returns—or whether defensive positioning continues to dominate crypto flows.Article Summary by TokenPost.ai

🔎 Market Interpretation

{

"price_action": [

"BTC hovered near the $70,000 psychological level, trading around $70,489 (-0.94%), signaling consolidation rather than a breakout.",

"Thinning spot/derivatives volume (24h volume ~ $44.96B, -2.37%) points to reduced conviction and near-term volatility compression.",

"Recent sessions show choppy, two-way trade (mix of sharp down days and modest rebounds), implying stabilization after a drop but fragile momentum."

],

"macro_context": [

"Risk-off backdrop: S&P 500 dipped while gold jumped, consistent with defensive positioning that can cap crypto upside follow-through.",

"Market attention is not expanding: Google Trends slipped, suggesting the bounce is led by existing participants rather than new inflows."

],

"sentiment_and_positioning": [

"Fear remains elevated (Fear & Greed Index at 31), keeping risk appetite subdued.",

"Bitcoin dominance rose to 58.30%, often indicating capital rotating toward BTC and away from altcoins during uncertainty."

],

"signals_snapshot": [

"Daily MACD stays positive but is losing slope (bullish impulse fading).",

"Weekly MACD remains deeply negative, reinforcing medium-term downside pressure despite short-term stabilization."

],

"liquidity_and_onchain": [

"SSR eased slightly (10.13 from 10.31), implying marginally better stablecoin relative ‘dry powder,’ but the change is neutral.",

"NUPL fell (0.2226 from 0.2367), indicating a smaller unrealized profit cushion, which can dampen speculative risk-taking while still allowing intermittent profit-taking.",

"Exchange balances dipped slightly and net flows stayed negative (-1,523 BTC), suggesting limited immediate sell pressure but also not a strong catalyst for upside.",

"Active wallets ticked up marginally, pointing to incremental engagement rather than a decisive trend-reversal surge."

],

"bottom_line": "The $70,000 area is acting as a consolidation battleground; the next major move likely depends on whether new liquidity returns to overcome risk-off conditions and fearful sentiment."

}

💡 Strategic Points

{

"key_levels_to_watch": [

"$70,000 as the primary psychological and tactical defense zone; sustained losses below it would likely worsen sentiment and invite momentum selling.",

"Upside attempts need confirmation via rising volume and improved risk appetite (macro + sentiment) to avoid another failed rebound."

],

"what_confirmation_might_look_like": [

"Volume expansion alongside price gains (spot + derivatives) to indicate real participation rather than thin-liquidity drift.",

"Sentiment improvement (Fear & Greed rising out of ‘fear’) and/or renewed public interest (search trends stabilizing/rising).",

"Weekly momentum stabilization (weekly MACD deterioration slowing) to reduce medium-term downside overhang."

],

"risk_management_takeaways": [

"In low-volume consolidation, false breakouts become more common—consider tighter execution rules and clearer invalidation points.",

"Dominance rising suggests altcoins may underperform BTC in the near term; positioning may skew defensive until risk appetite returns.",

"Monitor exchanges and net flows for a change from mild withdrawals to inflows, which can raise near-term sell risk if paired with weakening price."

],

"scenario_map": {

"bullish_case": "Liquidity returns + volume rises + risk-off pressure eases; BTC holds $70K and transitions from consolidation to a trend attempt.",

"base_case": "Range-bound chop persists around $70K with muted volume and mixed momentum signals.",

"bearish_case": "Macro stays defensive and weekly momentum dominates; $70K fails with limited dip-buying, increasing downside follow-through risk."

}

}

📘 Glossary

{

"MACD": "Moving Average Convergence Divergence; a momentum indicator. Positive can suggest upward momentum, but slowing improvement can indicate weakening impulse. Weekly MACD reflects longer time-frame trend pressure.",

"Bitcoin_dominance": "BTC’s share of total crypto market capitalization. Rising dominance often indicates investors are consolidating into BTC over altcoins during uncertainty.",

"Fear_and_Greed_Index": "A composite sentiment gauge (0–100). Lower scores reflect fear and reduced risk appetite.",

"SSR": "Stablecoin Supply Ratio; compares Bitcoin market cap to stablecoin supply to approximate stablecoin ‘buying power’ relative to BTC. Lower SSR can imply relatively more stablecoin liquidity.",

"NUPL": "Net Unrealized Profit/Loss; measures aggregate unrealized gains/losses on-chain. Falling NUPL suggests a shrinking profit cushion and potentially more cautious behavior.",

"exchange_balances_and_net_flows": "BTC held on exchanges and the net amount moving in/out. Falling balances and negative net flows can imply reduced immediate sell pressure, though magnitudes matter.",

"active_wallets": "A proxy for network participation/activity. A small increase suggests incremental use rather than a decisive demand surge.",

"volatility_compression": "A phase where price ranges narrow and large moves become less frequent; often precedes a larger directional move but does not predict direction by itself."

}

The major gold trade association, World Gold Council, and the Boston Consulting Group have proposed a new platform to modernize how the precious metal operates in digital financial systems.

The World Gold Council said on Thursday that it published a white paper on “Gold as a Service,” a new platform to “support the issuance and operation of scalable, interoperable digital gold products.”

The open platform would connect the physical custody of gold with the digital systems used to issue and manage tokenized gold products. 

“By standardizing essential market processes such as custody coordination, reconciliation, compliance, and redemption, the model aims to reduce operational complexity, improve access, and enable greater consistency across digital gold products,” the World Gold Council said. 

Crypto-native tokenized gold products include Tether Gold (XAUT) or Pax Gold (PAXG), which have formed their own custody, compliance and redemption models, but the World Gold Council’s standard could have more sway with institutions due to the trade group’s prominence.

Features include audits, fungibility, and liquidity Key features of the Gold as a Service would include standardizing tokenized gold issuance and management, increasing digital gold’s fungibility, embedding audits and assurance, enabling interoperability with existing finance rails, and improving liquidity in lending and borrowing markets. 

World Gold Council CEO, David Tait, said that financial services are undergoing a “rapid and pervasive digital transformation” and gold must also evolve to maintain its role in the global financial system. 

“Shared infrastructure can help gold become more accessible, more easily traded and fully integrated into modern financial systems — ensuring it remains as relevant tomorrow as it has been for millennia,” he added.

Matthias Tauber, a managing director and senior partner at Boston Consulting Group, said, “The question is no longer whether gold will be digital; it’s how it can participate in modern financial systems without compromising physical integrity.” 

Commodities are 20% of tokenized asset marketAccording to RWA.xyz, tokenized commodities such as gold account for around $5.5 billion, or 20% of the total on-chain value of tokenized real-world assets, a segment that has grown by 340% over the past 12 months, as demand for gold has skyrocketed. 

Tether’s tokenized gold product has a market capitalization of $2.6 billion, up 17% over the past 12 months, while Pax Gold has a market cap of $2.3 billion, according to CoinGecko. 

On Thursday, crypto exchange Bybit launched a yield-bearing tokenized gold product that lets users earn interest on Tether Gold. 

Tokenized gold and commodities represent 20% of the entire tokenized RWA market. Source: RWA.xyz
Magazine: Are DeFi devs liable for the illegal activity of others on their platforms?

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

XRP’s cheat sheet is pointing to higher levels this year. This cheat sheet is based on a 12-year cycle chart shared by analyst Cryptollica, who also suggests the asset is positioned for a major move higher on the social media platform X. The Relative Strength Index is also now pointing to oversold on the weekly timeframe, so the question is no longer whether the token can break above double-digit territory but when this will happen.

A 12-Year Structure That Keeps Repeating The XRP cheat sheet is a projection that shows XRP’s behavior across multiple cycles, showing how XRP has been playing out over the past 12 years. The chart spanning from 2014 to 2026 shows that the altcoin has respected a long-term ascending support line marked by multiple higher lows since 2018.

Each touch of this support trendline in past cycles has always led to a strong upward move. The 2020 low, the 2021 low, and the more recent accumulation zones visible in 2023 and 2025 all found support near the same rising trendline. At the same time, a descending resistance line cuts across previous peaks, except for the 2025 peak, when it broke above it.

Source: Chart from Cryptollica on X Interestingly, this is not the first time the altcoin has broken out of a similar triangle structure. As seen on the left side of the chart, price action between 2014 and 2017 formed a tight compression pattern, with lower highs pressing against a gradually rising base. That structure eventually resolved with a breakout in 2017, which carried into the 2018 peak. Now, XRP’s price action since 2025 has been playing out similarly to how it happened in 2018, although now on a larger and more drawn-out scale.

Breakout To Double Digits According to the analysis, the weekly RSI recently dropped to 29, which is a huge oversold condition. Notably, this is the same zone from which XRP launched every significant upward move in its trading history.

The last time its monthly RSI dropped to comparable lows was during the 2022 bear market, when the price reached a cycle bottom of $0.2910. That RSI reading was the floor, and XRP recorded only higher lows from that point forward.

If history is any indicator, then XRP is expected to keep on registering higher lows on the weekly timeframe, which, in turn, would translate to increasingly higher price levels in the coming weeks and months. 

Looking at the cheat sheet above, the chart’s upper channel boundary, when projected from the 2017/2018 peak, puts the cryptocurrency finally breaching the $10 price level. Interestingly, the idea of XRP moving above $10 is not isolated to a single chart. It continues to show up across multiple long-term theses with different timelines.

Some projections place the altcoin in the $15 to $30 range under favorable conditions like regulatory clarity. More conservative voices place near-term ceilings considerably lower. For instance, crypto analyst EGRAG CRYPTO predicted that XRP will peak at $8.5 between 2026 and 2027.

XRP trading at $1.46 on the 1D chart | Source: XRPUSDT on Tradingview.com Featured image from Freepik, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter! For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts. Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

Zach Anderson Mar 20, 2026 06:02

Circle's open-source toolkit helps Claude and other AI assistants build stablecoin apps with proper implementation patterns, reducing developer guesswork.

Circle has released detailed documentation showing how developers can use its open-source Circle Skills library to build cross-chain USDC applications through AI assistants like Claude—a move that could accelerate stablecoin integration as USDC's circulation now exceeds $77 billion.

The toolkit, which launched earlier this month, doesn't just give AI models generic coding ability. It provides decision frameworks for Circle-specific workflows: when to use CCTP versus Gateway for cross-chain transfers, which wallet model fits a particular use case, and how USDC contracts behave differently across chains.

Why This Matters for BuildersAnyone who's prompted an AI to build something complex knows the pattern. The code looks right, compiles fine, then falls apart once you hit edge cases the model didn't anticipate. Circle Skills addresses this by feeding Claude structured context about Circle's product ecosystem before it starts generating code.

The practical difference shows up in implementation choices. In Circle's example—building an app that moves USDC from Ethereum Sepolia to Arc Testnet—Claude automatically selected Dev-Controlled Wallets with Smart Contract Accounts rather than raw key management. It wrapped the transfer in Bridge Kit instead of manually coordinating approve, burn, attestation, and mint steps.

These aren't obvious decisions for a general-purpose AI model. They're the kind of architectural choices that typically require reading documentation, hitting dead ends, and refactoring.

Technical SetupInstallation runs through Claude Code's plugin system:

/plugin marketplace add circlefin/skills
/plugin install circle-skills@circle

From there, prompts can be surprisingly direct. Circle's example used: "Use Circle Skills to build a sample app that moves USDC from Ethereum Sepolia to Arc Testnet, using Dev-Controlled Wallets with one wallet created on each chain."

Claude identified the relevant skills—circle:bridge-stablecoin and circle:use-developer-controlled-wallets—and structured the project around Circle's SDKs rather than lower-level API calls.

Market ContextThe timing coincides with renewed institutional interest in stablecoin infrastructure. Circle's stock surged 126% in recent trading amid what analysts describe as USDC's "market resilience." The company appears to be betting that developer tooling—particularly AI-assisted tooling—will drive the next wave of stablecoin adoption.

For teams building payment applications, treasury management systems, or cross-chain bridges, Circle Skills could meaningfully compress development timelines. The library is open source and supports Cursor, Claude Code, and OpenAI Codex.

Whether AI-assisted development becomes standard practice for blockchain applications remains an open question. But Circle is clearly positioning its infrastructure to be AI-native from the start.

Image source: Shutterstock

usdc circle ai development cross-chain stablecoins

Dogecoin started a fresh decline below the $0.0980 zone against the US Dollar. DOGE is now consolidating losses and might face hurdles near $0.0950 and $0.0980.

DOGE price started a fresh decline below the $0.0965 level. The price is trading below the $0.0965 level and the 100-hourly simple moving average. There is a bearish trend line forming with resistance at $0.0950 on the hourly chart of the DOGE/USD pair (data source from Kraken). The price could extend losses if it stays below $0.0950 and $0.0980. Dogecoin Price At Risk of More Downside Dogecoin price started a fresh decline after it closed below $0.0980, like Bitcoin and Ethereum. DOGE declined below the $0.0965 and $0.0950 support levels.

The price even traded below $0.0925. A low was formed near $0.0917, and the price is now showing bearish signs. There was a recovery wave above $0.0940, but the price stayed below the 23.6% Fib retracement level of the downward move from the $0.1044 swing high to the $0.0917 low.

Dogecoin price is now trading below the $0.0950 level and the 100-hourly simple moving average. If there is a recovery wave, immediate resistance on the upside is near the $0.0950 level. There is also a bearish trend line forming with resistance at $0.0950 on the hourly chart of the DOGE/USD pair.

The first major resistance for the bulls could be near the $0.0980 level and the 50% Fib retracement level of the downward move from the $0.1044 swing high to the $0.0917 low. The next major resistance is near the $0.10 level.

Source: DOGEUSD on TradingView.com A close above the $0.10 resistance might send the price toward the $0.1050 resistance. Any more gains might send the price toward the $0.1080 level. The next major stop for the bulls might be $0.1120.

More Losses In DOGE? If DOGE’s price fails to climb above the $0.0950 level, it could continue to move down. Initial support on the downside is near the $0.0920 level. The next major support is near the $0.0880 level.

The main support sits at $0.0850. If there is a downside break below the $0.0850 support, the price could decline further. In the stated case, the price might slide toward the $0.0800 level or even $0.0750 in the near term.

Technical Indicators

Hourly MACD – The MACD for DOGE/USD is now losing momentum in the bearish zone.

Hourly RSI (Relative Strength Index) – The RSI for DOGE/USD is now below the 50 level.

Major Support Levels – $0.0920 and $0.0880.

Major Resistance Levels – $0.0950 and $0.0980.